Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
AIFA · 94 medicines
SFDA · 82 medicines · Historical list
FDA · 66 medicines
HSA · 52 medicines
AEMPS · 50 medicines
CBG-MEB · 30 medicines
HALMED · 23 medicines
PHARMAC · 17 medicines
MS · 17 medicines · Historical list
TFDA · 16 medicines
ALIMS · 15 medicines
EMA · 2 medicines · Historical list
Show all 2Every register, a page at a time. Strengths and packs are on each medicine’s page.
50 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Betametasona Sonphar 0,5 MG/ML Gotas Orales en Solucion Efg | Spain | 50 mg | gotas orales en solución | Marketed | Laboratorios Sonphar S.L. |
| Calcipotriol/Betametasona Ratiopharm 50 Microgramos/G + 0,5 MG/G PomadaCombination | Spain | 0,050 mg + 0,643 mg | pomada | Marketed | Teva Pharma S.L.U. |
| Beta-Micoter 10 MG/G + 0,5 MG/G CremaCombination | Spain | 0,05 g + 1 g | crema | Marketed | Teofarma S.R.L. |
| Calcipotriol/Betametasona Aristo 50 Microgramos/G + 0,5 MG/G GelCombination | Spain | 0,052 mg + 0,643 mg | gel | Authorised | Aristo Pharma Gmbh |
| BETNOVATE 1 mg/g CREMA | Spain | 0,1 g | crema | Marketed | Industrial Farmaceutica Cantabria S.A. |
| BETNOVATE 1 mg/g SOLUCION CUTANEA | Spain | 0,1 P/P | solución cutánea | Marketed | Industrial Farmaceutica Cantabria S.A. |
| Fusicutanbeta 20 MG/G + 1 MG/G CremaCombination | Spain | 20.40 mg + 1.214 mg | crema | Marketed | Mibe Pharma España S.L.U. |
| Celestone Cronodose Suspension Inyectable | Spain | 6 mg + 7,89 mg | suspensión inyectable | Marketed | Organon Salud S.L. |
| FUCIBET 20 mg/g + 1 mg/g CREMACombination | Spain | 2 g + 0,1 g | crema | Marketed | Laboratorios Leo Pharma S.A. |
| Mibetin 0,5 MG/G + 1 MG/G CremaCombination | Spain | 1,67 mg/g + 0,64 mg/g | crema | Marketed | Mibe Pharma España S.L.U. |
| Bronsal Solucion InyectableCombination | Spain | 200 mg + 2 mg + 250 mg | solución inyectable | Marketed | Ionfarma S.L. |
| Fucibet Lipid 20 MG/G + 1 MG/G CremaCombination | Spain | 20 mg/g + 1,214 mg/g | crema | Marketed | Leo Pharma A/S |
| DAIVOBET 50 microgramos/0,5 mg/g GELCombination | Spain | 50 µg + 0,5 mg | gel | Marketed | Leo Pharma A/S |
| DAIVOBET 50 microgramos/ 0,5 mg/g POMADACombination | Spain | 0,5 mg + 50 µg | pomada | Marketed | Leo Pharma A/S |
| Befudin 20 MG/G + 1 MG/G CremaCombination | Spain | 20 mg/g + 1,214 mg/g | crema | Authorised | Laboratoires Medgen |
| ALERGICAL 0,5 mg/ 0,1mg/g CREMACombination | Spain | 0,1 mg + 0,5 mg | crema | Marketed | Faes Farma S.A. |
| CELECREM 0,5 mg/g CREMA | Spain | 0,5 mg | crema | Marketed | Galenicum Derma S.L.U. |
| CELECREM 1 mg/g CREMA | Spain | 1 mg | crema | Marketed | Galenicum Derma S.L.U. |
| CELESTODERM 1 mg/g + 1 mg/g CREMACombination | Spain | 1 mg + 1,22 mg | crema | Marketed | Organon Salud S.L. |
| Cuatrocrem CremaCombination | Spain | 1 mg + 10 mg + 0,5 mg + 10 mg | crema | Marketed | Galenicum Derma S.L.U. |
| DIPRODERM 0,5 mg/g CREMA | Spain | 0,64 mg | crema | Marketed | Organon Salud S.L. |
| DIPRODERM 0,5 mg/g POMADA | Spain | 0,64 mg | pomada | Marketed | Organon Salud S.L. |
| DIPRODERM 0,5 mg/g SOLUCION CUTANEA | Spain | 0,64 mg | solución cutánea | Marketed | Organon Salud S.L. |
| DIPROGENTA 0,5 mg/g + 1 mg/g cremaCombination | Spain | 1,00 mg + 0,64 mg | crema | Marketed | Organon Salud S.L. |
| Diprosalic PomadaCombination | Spain | 0,64 mg + 30 mg | pomada | Marketed | Organon Salud S.L. |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada, HSA, MS, PHARMAC, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
